Urology
News, opinions and meeting coverage in urology.
FDA Warns of High-Grade Prostate Ca Risk With BPH Drugs
WASHINGTON -- The FDA has issued a warning of an increased risk of high-grade prostate cancer with the 5-alpha reductase inhibitors finasteride (Proscar) and dutasteride (Avodart), currently approved to treat benign prostatic hypertrophy.
Jun 09, 2011
Men Encouraged to Consider Medication to Prevent Prostate Cancer
ALEXANDRIA, Va. -- Millions of healthy men ages 55 and older should talk to their physicians about taking a 5-alpha reductase inhibitor such as finasteride (Proscar) or dutasteride (Avodart) to prevent prostate cancer, according to a guideline issued by two medical groups.
Feb 25, 2009
Researcher Retreats on Sexual Enhancement Claim for Watermelon
COLLEGE STATION, Tex. -- Chalk up the widely publicized report that watermelons can enhance erections, much like a certain PDE-5 inhibitor, to a stretched version of the truth by a university PR officer seeking a good story for the Fourth of July.
Jul 03, 2008